Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of duloxetine compared with
placebo for reducing fatigue in patients diagnosed with Chronic Fatigue Syndrome (CFS).